Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News PepGen Inc PEPG

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO... see more

Current News (NDAQ:PEPG)

Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Shareholders to Connect

ACCESS Newswire January 4, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PepGen Inc. (PEPG) And Encourages Shareholders to Reach Out

ACCESS Newswire January 1, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Shareholders to Learn More About the Investigation

ACCESS Newswire December 30, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

ACCESS Newswire December 28, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire December 25, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Investors to Connect

ACCESS Newswire December 23, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Stockholders to Inquire about Securities Investigation

ACCESS Newswire December 21, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Investors to Learn More About the Investigation

ACCESS Newswire December 18, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire December 16, 2025

Opinion & Analysis (NDAQ:PEPG)

No current opinion is available.

Bullboard Posts (NDAQ:PEPG)

PEPG....last 1/2 hr heroics

Let f'king Gooooooo
Iseneschal - September 26, 2025

PEPG....Yesssss...now $6.

Many attempts over $6 this a.m Might stick and go higher No Position
Iseneschal - September 25, 2025

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway,so good luck to all of you guys
coolfooldumbguy - September 25, 2025

PEPG....Lots of Volume in the PM opening....over $6.00

Price action is marginal post AH trading Patience
Iseneschal - September 25, 2025

PEPG...remember what happened to QURE after the P.O NR?

Well put this on watch....currently up $3.74 and trading at $5.69 Cheers !
Iseneschal - September 24, 2025

PEPG.....NR x's 2 just after the close

1 NR )    epGen Announces Highest Mean Splicing Correction Reported in DM1 Patients   2025-09-24 13:16 ET - News...
Iseneschal - September 24, 2025